Company profile: OPX Biotechnologies
1.1 - Company Overview
Company description
- Provider of bioengineering technology to convert renewable feedstocks into biofuels and green chemistry products, leveraging its proprietary OPX EDGE (Efficiency Directed Genome Engineering) platform for rapid, rational, and robust optimization of microbes and bioprocesses; Colorado-based.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to OPX Biotechnologies
Amyris
HQ: United States
Website
- Description: Provider of biotech chemical products made via advanced sugarcane-derived fermentation. Portfolio includes Neossance Squalane for cosmetics and skincare moisturization and barrier repair; Artemisinic Acid used in antimalarial treatments; Biosilica from sugarcane ashes for cosmetics; Neossance Hemisqualane as a plant-based silicone alternative; Biofene renewable specialty chemical building block; RealSweet Reb M zero-calorie sweetener.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amyris company profile →
Iveric Bio
HQ: United States
Website
- Description: Provider of science-driven biopharmaceutical research and development focused on novel treatment options for retinal diseases with significant unmet medical needs, including age-related macular degeneration, developing therapeutic product candidates for age-related retinal diseases and gene therapy product candidates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iveric Bio company profile →
Automated Lab Solutions
HQ: Germany
Website
- Description: Provider of life science robotics and automation, including the CellCelector automated system for fluorescence imaging, selection, and image-based sorting/picking of single cells, clusters, adherent cell colonies, and clones from semi-solid media; rare single cell isolation; single cell cloning; stem cell picking; the Incubator FlowBox laminar flow cabinet; and automation components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Automated Lab Solutions company profile →
Treos Bio
HQ: United Kingdom
Website
- Description: Provider of computational immunology solutions that predict in silico likely responders to cancer immunotherapies and design next-generation targeted immunotherapies tailored to patient genetics; offers PolyPEPI1018 for metastatic colorectal cancer (developed without need for tumor biopsy), PEPI Panel to create personalized therapies based on tumor type and HLA genotype, PolyPEPI-SCoV-2 preventive vaccine, and PEPI Test predicting peptide-specific T cell responses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Treos Bio company profile →
Checkerspot
HQ: United States
Website
- Description: Provider of biomanufactured performance materials and ingredients, leveraging the WING platform to design at a molecular level. Offerings include High Oleic Algae Oil for industrial and food applications; algae-based Checkerspot Cast PU elastomers and Rigid PU Foam; miDori bioWick textile finish for moisture management; and SpiralMade recycled composite materials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Checkerspot company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for OPX Biotechnologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OPX Biotechnologies
2.2 - Growth funds investing in similar companies to OPX Biotechnologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for OPX Biotechnologies
4.2 - Public trading comparable groups for OPX Biotechnologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →